Suppr超能文献

金沙萨省常规护理中妊娠和哺乳期妇女的 HIV 病毒抑制情况:CQI-PMTCT 研究参与者的基线评估。

HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study.

机构信息

Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.

School of Public Health, The University of Kinshasa, Kinshasa, Democratic Republic of Congo.

出版信息

J Int AIDS Soc. 2019 Sep;22(9):e25376. doi: 10.1002/jia2.25376.

Abstract

INTRODUCTION

Published data on viral suppression among pregnant and breastfeeding women in routine care settings are scarce. Here, we report provincial estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors.

METHODS

This cross-sectional study was conducted as part of a baseline assessment for the CQI-PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous quality interventions (CQI) on long-term ART outcomes among pregnant and breastfeeding women (NCT03048669). From November 2016 to June 2018, in each of the 35 Kinshasa provincial health zones (HZ), study teams visited the three busiest maternal and child health clinics, enrolled all HIV-positive pregnant or breastfeeding women (≤1 year post-delivery) receiving ART, and performed viral load testing. Log binomial models with generalized estimating equations to account for clustering at the HZ level, were used to estimate prevalence ratios comparing participants with undetected (<40 copies/mL) or suppressed (<1000 copies/mL) viral load across levels of individual and site characteristics.

RESULTS

Of the 1752 eligible women, 1623 had viral load results available, including 38% who had been on ART for <6 months and 74% were on tenofovir-lamivudine-efavirenz. Viral load was undetectable in 53% of women and suppressed in 62%. Among women who were on ART for ≥12 months, only 60% and 67% respectively, had undetectable or suppressed viral load. Viral load was undetectable in 53%, 48% and 58% of women testing during pregnancy, at delivery, and in postpartum respectively. In multivariable log binomial models, duration of ART >12 months, older age, being married, disclosure of HIV status, receiving care in an urban health zone or one supported by PEPFAR were all positively associated with viral suppression.

CONCLUSIONS

The observed high level of detectable viral load suggests that high ART coverage alone without substantial efforts to improve the quality of care for pregnant and breastfeeding women, will not be enough to achieve the goal of virtual elimination of vertical HIV transmission in high-burden and limited resources settings like DRC.

摘要

简介

在常规护理环境中,关于孕妇和哺乳期妇女病毒抑制的数据很少。在这里,我们报告了在刚果民主共和国金沙萨的艾滋病毒护理中,孕妇和哺乳期妇女的不可检测和抑制病毒载量的省级估计值,以及相关的危险因素。

方法

这项横断面研究是 CQI-PMTCT 研究的基线评估的一部分:这是一项正在进行的集群随机试验,旨在评估连续质量干预(CQI)对孕妇和哺乳期妇女长期 ART 结果的影响(NCT03048669)。从 2016 年 11 月至 2018 年 6 月,在金沙萨的 35 个省级卫生区(HZ)中,研究小组访问了三个最繁忙的母婴保健诊所,招募了所有正在接受 ART 治疗的 HIV 阳性孕妇或哺乳期妇女(分娩后≤1 年),并进行了病毒载量检测。使用广义估计方程的对数二项式模型来考虑 HZ 水平的聚类,以估计个体和站点特征水平上不可检测(<40 拷贝/毫升)或抑制(<1000 拷贝/毫升)病毒载量的参与者之间的患病率比。

结果

在 1752 名符合条件的妇女中,有 1623 名妇女的病毒载量结果可用,其中 38%的妇女接受 ART 治疗时间<6 个月,74%的妇女接受替诺福韦-拉米夫定-依非韦伦治疗。53%的妇女病毒载量不可检测,62%的妇女病毒载量抑制。在接受 ART 治疗≥12 个月的妇女中,分别只有 60%和 67%的妇女病毒载量不可检测或抑制。在怀孕期间、分娩时和产后分别有 53%、48%和 58%的妇女病毒载量不可检测。在多变量对数二项式模型中,ART 治疗时间>12 个月、年龄较大、已婚、HIV 状态披露、在城市卫生区或接受 PEPFAR 支持的卫生区接受护理与病毒抑制呈正相关。

结论

观察到的可检测病毒载量水平很高,这表明,仅靠高抗逆转录病毒治疗覆盖率,而不大力改善孕妇和哺乳期妇女的护理质量,在资源有限的高负担国家,如刚果民主共和国,将不足以实现垂直 HIV 传播虚拟消除的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b76e/6732557/ee6b7a25a4b5/JIA2-22-e25376-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验